week 2 semaglutide no weight loss tirzepatide pros and cons for A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss semaglutide week 2 no weight

The STEP trials documented mean resting heart rate increases of 1.64.0 beats per minute in semaglutide-treated patients compared to placebo

Patients should monitor for signs that might suggest complications, including: Persistent lumps lasting beyond 24-48 hours Increasing size, hardness, or tenderness at the injection site Redness, warmth, or signs of inflammation suggesting possible infection Bruising or bleeding that seems excessive Itching, rash, or hives indicating potential allergic reaction According to the UK Summary of Product Characteristics for Ozempic, injection site reactions are classified as 'uncommon' (may affect up to 1 in 100 people)

Images were captured using a photo scanner (Epson, Tokyo)

( 5 ) For men who may not meet the threshold for diabetes but still struggle with obesity or metabolic syndrome, these drugs can now be utilized to help you revitalize your health

Highlights GLP-1RAs improve PsO severity and metabolic parameters other than weight loss in PsO